Published in

Elsevier, Epilepsy & Behavior, 3(10), p. 417-425

DOI: 10.1016/j.yebeh.2007.01.004

Links

Tools

Export citation

Search in Google Scholar

Sertraline and fluoxetine: Safe treatments for children and adolescents with epilepsy and depression

Journal article published in 2007 by M. S. Thomé-Souza, E. Kuczynski, K. D. Valente ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Red circle
Postprint: archiving forbidden
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Depression is frequent, underdiagnosed, and untreated in people with epilepsy. The lack of treatment is partially explained by the concerns over the proconvulsive effects of psychoactive drugs. There are few studies on the effects of selective serotonin reuptake inhibitors (SSRIs) in adults with epilepsy and none in children. The main purpose of the present study was to analyze the impact of SSRIs on the severity and frequency of seizures in children and adolescents with epilepsy and major depressive disorders. In addition, we also evaluated the efficacy of SSRIs in the treatment of depressive symptoms and side effects other than seizure aggravation.